News
![Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results: https://mms.businesswire.com/media/20191101005100/en/736004/5/Sangamo_logoTM.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzhpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--38b3f45f170b11880f9bbfb3e14c3e180b77ea27/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Sangamo_logoTM.jpg?locale=us)
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and third quarter 2022 financial results.
“This has been a year marked by
![BILL to Acquire Finmark, a Financial Planning and Analysis Software Company: https://mms.businesswire.com/media/20210506006167/en/1095511/5/Bill.com_logo_for_Business_Wire.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTErVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9b237e080e390352d92a7321833e5a05f2d8b311/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Billcom_logo_for_Business_Wire.jpg?locale=us)
BILL to Acquire Finmark, a Financial Planning and Analysis Software Company
BILL (NYSE: BILL), a leader in financial automation software for small and midsize businesses (SMBs), today announced it has signed a definitive agreement to acquire Finmark, a leading financial
![Align Technology and Desktop Metal Announce Strategic Collaboration to Make iTero Element™ Flex the Preferred Restorative Intraoral Scanner for Desktop Labs’ Customers Serving General Dentists: https://mms.businesswire.com/media/20220621005363/en/728102/5/Desktop_Metal_logo_horizontal.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXVxV0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e510144fe7857a064d13941e095b750b2bcc6e26/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Desktop_Metal_logo_horizontal.jpg?locale=us)
Align Technology and Desktop Metal Announce Strategic Collaboration to Make iTero Element™ Flex the Preferred Restorative Intraoral Scanner for Desktop Labs’ Customers Serving General Dentists
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners
![Upland Software Reports Third Quarter 2022 Financial Results : https://mms.businesswire.com/media/20191107006065/en/707094/5/Upland-Blue-cmyk.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOE1rRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e19aeda0e946c39275386b95727d34f75568ada6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Upland-Blue-cmyk.jpg?locale=us)
Upland Software Reports Third Quarter 2022 Financial Results
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the third quarter 2022 and issued guidance for
![Polaris Declares Regular Cash Dividend: https://mms.businesswire.com/media/20191223005031/en/764313/5/600x100_polaris_black_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWhJR1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b8ce01393d2f7d0c3eb3f1227b00fca638e3818a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/600x100_polaris_black_logo.jpg?locale=us)
Polaris Declares Regular Cash Dividend
Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.64 per share payable on December 15, 2022 to shareholders of record at the
![Skyworks Reports Q4 and Full Year FY22 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24761/300px-Skyworks_Solutions_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBa1VCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--12e2f9076b464fff5d28832031248f53ee13717d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/300px-Skyworks_Solutions_logo.png?locale=us)
Skyworks Reports Q4 and Full Year FY22 Results
Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed signal semiconductors connecting people, places and things, today reported fourth fiscal quarter and
![Cushman & Wakefield Reports Financial Results for the Third Quarter 2022: https://mms.businesswire.com/media/20191105006169/en/669112/5/CW_Logo_Color_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzRuRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--95f78d8fd6ba05479cc9abb10412af470a22a6b9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CW_Logo_Color_-28002-29.jpg?locale=us)
Cushman & Wakefield Reports Financial Results for the Third Quarter 2022
Cushman & Wakefield (NYSE: CWK) today reported financial results for the third quarter of 2022:
Year-to-Date Results:
-
Revenue of $7.5 billion and service line fee revenue of $5.4 billion for
![VICI Properties Inc. Announces Public Offering of Common Stock: https://mms.businesswire.com/media/20201118006119/en/840126/5/caesars+logo_highres.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXFjVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--48fabea00e7f4e84dec00f04c60adf71c810e44e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/caesars+logo_highres.jpg?locale=us)
VICI Properties Inc. Announces Public Offering of Common Stock
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”), an experiential asset real estate investment trust, today announced it has commenced an underwritten public offering of
![Atlassian Announces First Quarter Fiscal Year 2023 Results: https://mms.businesswire.com/media/20221103006245/en/649647/5/Atlassian-horizontal-blue%402x-rgb.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGxlV1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8c4fac30721b6830798e1fe07979b0fe639dea1a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Atlassian-horizontal-blue-402x-rgb.jpg?locale=us)
Atlassian Announces First Quarter Fiscal Year 2023 Results
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its first quarter of fiscal year 2023 ended September
![Cognex Increases Quarterly Cash Dividend: https://mms.businesswire.com/media/20200102005333/en/16666/5/cognexblacklogo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNTVJR3c9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8892bc7ea5899b13f36bc52b7c4b4995f0c48c9d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/cognexblacklogo.jpg?locale=us)
Cognex Increases Quarterly Cash Dividend
Cognex Corporation (NASDAQ: CGNX) today announced that the company's Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on December 2, 2022 to all shareholders of
![Origin Materials, Inc. Reports Financial Results for Third Quarter 2022: https://mms.businesswire.com/media/20211201005247/en/931722/5/Logo_New.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNCtUVnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c95e906241a8e0dd614934134a90e987ea33fbd4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Logo_New.jpg?locale=us)
Origin Materials, Inc. Reports Financial Results for Third Quarter 2022
Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to enable the world’s transition
![Connection (CNXN) Reports Third Quarter 2022 Results: https://mms.businesswire.com/media/20200512005920/en/791247/5/Connection_Corp_logo_tall_4c_highres.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmdETlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--09ff82277de113be309aa0592edfadcad9ac34b0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Connection_Corp_logo_tall_4c_highres.jpg?locale=us)
Connection (CNXN) Reports Third Quarter 2022 Results
Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, healthcare and education markets, today announced results for the third
![MedinCell’s Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023: https://mms.businesswire.com/media/20191128005494/en/700687/5/MedinCell-Logo-notagline.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1lrRkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffe7117f65769c1af8e7c864c31c1f8dee36a72c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/MedinCell-Logo-notagline.jpg?locale=us)
MedinCell’s Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023
MedinCell’s (Paris:MEDCL) partner, Teva, today announced that it recently completed the re-submission to a New Drug Application to the U.S. FDA for mdc-IRM, a risperidone subcutaneous Long-Acting
![Nutrien Declares Quarterly Dividend of US$0.48 per Share: https://mms.businesswire.com/media/20191104006030/en/699432/5/Nutrien_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e3497280ba634d92aadbfc5a122d051780b36337/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nutrien_logo.jpg?locale=us)
Nutrien Declares Quarterly Dividend of US$0.48 per Share
Nutrien Ltd (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.48 per share payable on January 13, 2023, to shareholders of record on December
![EQS-Adhoc: 11880 Solutions AG announces preliminary Q3 results and adjusts annual forecast](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
EQS-Adhoc: 11880 Solutions AG announces preliminary Q3 results and adjusts annual forecast
![Cryptology’s estimated NAV per share as of 02/11/2022 is €4.92](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Cryptology’s estimated NAV per share as of 02/11/2022 is €4.92
![Acadia Healthcare to Participate in Credit Suisse 31st Annual Healthcare Conference: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGxvTXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9495f97191ece669fac2cb2dda5975e1824b4da8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ACHC.jpg?locale=us)
Acadia Healthcare to Participate in Credit Suisse 31st Annual Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Credit Suisse 31st Annual Healthcare Conference, November 7 - 10, 2022, at Terranea Resort in
![PhosAgro PJSC: PhosAgro Reports Operating and Financial Results for 9M 2022](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
PhosAgro PJSC: PhosAgro Reports Operating and Financial Results for 9M 2022
![Fuller, Smith & Turner PLC: Transaction in Own Shares](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Fuller, Smith & Turner PLC: Transaction in Own Shares
![PhosAgro PJSC: PhosAgro’s Board of Directors Notes Significant Progress in Implementing the Company’s Climate Strategy](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
PhosAgro PJSC: PhosAgro’s Board of Directors Notes Significant Progress in Implementing the Company’s Climate Strategy
![Rights and Issues Investment Trust PLC: Transaction in Own Shares](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Rights and Issues Investment Trust PLC: Transaction in Own Shares
![EQS-Adhoc: Progress-Werk Oberkirch AG: PWO reports figures for the first 9 months of 2022 and raises forecasts for the current fiscal year](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-Adhoc: Progress-Werk Oberkirch AG: PWO reports figures for the first 9 months of 2022 and raises forecasts for the current fiscal year
![EQS-Adhoc: JOST Werke AG: JOST raises guidance for fiscal year 2022 and publishes preliminary interim results for the first nine months of 2022](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
EQS-Adhoc: JOST Werke AG: JOST raises guidance for fiscal year 2022 and publishes preliminary interim results for the first nine months of 2022
![PAO Severstal: ANNOUNCEMENT OF CONSENT SOLICITATION RESULTS](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
PAO Severstal: ANNOUNCEMENT OF CONSENT SOLICITATION RESULTS
![Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myelomahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the